Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04446247 · ClinicalTrials.gov registry record

Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia

A clinical trial of Hypoxia, sponsored by Owlet Baby Care.

Completed
Registry status
14
Enrollment target
1
Study location

NCT04446247: Completed study of Hypoxia, sponsored by Owlet Baby Care.

NCT04446247 is a study of Hypoxia that has completed, run by Owlet Baby Care. The registered enrollment target is 14 participants, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04446247, a study of Hypoxia, has completed, sponsored by Owlet Baby Care.

COMPLETED
Registry status
14 participants
Enrollment target
1
Study location

Study Summary

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.

Primary Outcome

Determination of Average Root Mean Square SpO2 Accuracy of the Owlet Smart Sock 3rd Generation

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Owlet Smart Sock Sensor 3rd Generation

Study Locations (1)

California

  • University California San Fransisco, Department of Anesthesia - San Francisco

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2020-03-12
Est. Completion 2020-03-13
Owlet Baby Care

9 total trials

What the finished NCT04446247 record still lists

NCT04446247 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 3,117-participant average among 39 other Hypoxia trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Owlet Smart Sock Sensor 3rd Generation is the first listed.

NCT04446247 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04446247 about?

NCT04446247 is a clinical study titled "Accuracy of Owlet Smart Sock Sensor 3rd Generation With Profound Hypoxia". Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This ...

What is the current status of trial NCT04446247?

This trial is currently completed. The enrollment target is 14 participants. The study started on 2020-03-12. Estimated completion is 2020-03-13.

What conditions does trial NCT04446247 study?

This clinical trial studies the following conditions: Hypoxia.

What interventions are being tested in trial NCT04446247?

The interventions under investigation include: Owlet Smart Sock Sensor 3rd Generation (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04446247?

This trial is sponsored by Owlet Baby Care, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04446247 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04446247's enrollment target sits among peer trials

14 28th of 39 higher than 12 of 39 other Hypoxia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypoxia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04446247, the US trial registry maintained by the National Library of Medicine. NCT04446247 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.